Prevention of sternal wound infections after coronary artery bypass graft surgery with use of insulin drug therapy: A review of the literature

Dimensions of Critical Care Nursing

Volumn 28, Issue 5, 2009, Pages 199-203

  Killian, Maggie ^a   Russell, Anne C ^a   Keister, Kathy J ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Coronary artery bypass graft; Insulin; Sternal wound infections

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

CORONARY ARTERY BYPASS GRAFT; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; DRUG MONITORING; ECONOMICS; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; METHODOLOGY; PERIOPERATIVE PERIOD; REVIEW; RISK FACTOR; STERNUM; SURGICAL INFECTION; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; CRITICAL CARE; DIABETES COMPLICATIONS; DRUG MONITORING; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PERIOPERATIVE CARE; RISK FACTORS; STERNUM; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 69849106073     PISSN: 07304625     EISSN: 15388646     Source Type: Journal    
DOI: 10.1097/DCC.0b013e3181ac496b     Document Type: Review

References (16)

1. American Heart Association. Open heart surgery statistics. 2008. http://www.americanheart.org/presenter. Accessed October 5, 2008.
2. American Diabetic Association. Diabetes statistics. www.diabetes. org/diabetes-statistics.jsp. Accessed October 27, 2008.
3. Talbot TR. Diabetes mellitus and cardiothoracic surgical site infections. Am J Infect Control. 2005;33:353-359.
4. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;7:862-866.
5. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;33:352-362.
6. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. 2003. http:// www.providence.org/resources.htm. Accessed September 27, 2008.
7. Smiley DD, Umpierrez GE. Perioperative glucose control in the diabetic or nondiabetic patient. South Med J. 2006;6:580-589.
8. Guvener M, Pasaoglu I, Demircin M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;5:531-537.
9. Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoper-ative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008; 136:631-640.
10. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;10:607-612.
11. Kramer R, Groom R, Weldner D, et al. Glycemic control and reduction of deep sternal wound infection rates. Arch Surg. 2008;5:451-456.
12. Swenne CL, Lindholm C, Borowiec J, Schnell AE, Carlsson M. Perioperative glucose control and development of surgical wound infections in patients undergoing coronary artery bypass graft. J Hosp Infect. 2005;61:201-212.
13. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetes after open heart operations. Ann Thorac Surg. 1997; 63:356-361.
14. Hruska LA, Smith JM, Hendy MP, Fritz VL, McAdams S. Continuous insulin infusion reduces infectious complications in diabetics following coronary surgery. J Card Surg. 2005;20:403-407.
15. Cohen O, Danker R, Chetrit A, et al. Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG). Cardiovasc Surg. 2003;3:195-200.
16. Kelly JL, Hirsh IB, Furnary AP. Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers. Semin Thorac Cardiovasc Surg. 2006;18:346-358.